Avacta Group, a clinical stage oncology drug company developing cancer therapies and diagnostics based on its proprietary pre|CISION and Affimer platforms, has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists working on CRISPR/Cas9-mediated gene editing technology have developed a method to increase efficiency of editing while minimizing DNA deletion sizes, a key step toward developing gene editing therapies to treat genetic diseases.
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has discovered a new molecular pathway to govern melanoma angiogenesis and metastasis. The findings provide new insights into how melanoma undergoes metastasis and progression through secretion of pro-angiogenic factor to induce angiogenesis that paves the way for new therapeutic opportunities. The […]
Ziath has been awarded with a prestigious Queen’s Award for Enterprise (2022) in the International Trade category.
ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and centre of excellence for cell and gene therapy, will partner to improve viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres […]
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), are unveiling Xpert Alliance, a joint visualization of their strategic collaboration. The visualization is designed to “bring to life” this ongoing alliance and celebrate its successful operation, delivering effective solutions to address clients’ changing and expanding needs in the area of complex […]
Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, will collaborate to promote multiplexed immunofluorescence (mIF) assays and scalable AI applications to unlock spatial analysis in clinical research.
HORIBA UK has introduced a new network licence option for its QSP 2.0 (Quality Slide Program) [1] affordable digital tool for skill evaluation and training in morphology at IBMS Congress 2022. This now enables up to 50 users across various locations, even in different countries, to directly access this valuable digital morphology resource as it […]
CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, will collaborate with ExcellGene, a leading biologics Contract Development & Manufacturing Organizations (CDMO) that manufactures recombinant proteins, to streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing, which enables important improvements to the […]
Codexis and seqWell have announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, and seqWell, a developer of transformative library preparation products for demanding genomics applications, plan to collaborate on using Codexis’ CodeEvolver platform […]
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.